GBT

Global Blood Therapeutics, Inc.

Delisted

GBT was delisted on the 4th of October, 2022.

190 hedge funds and large institutions have $2.32B invested in Global Blood Therapeutics, Inc. in 2018 Q4 according to their latest regulatory filings, with 42 funds opening new positions, 65 increasing their positions, 62 reducing their positions, and 33 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
190
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$78.3M
Puts
$23.2M
Net Calls
Net Calls Change

Top Sellers

1 -$30.6M
2 -$20.8M
3 -$16.6M
4
NC
Nexthera Capital
New York
-$13.4M
5
Loomis, Sayles & Company
Loomis, Sayles & Company
Massachusetts
-$12.3M
Name Holding Trade Value Shares
Change
Change in
Stake
1
$342M
2
$223M
3
$189M
4
$173M
5
$152M
6
$129M
7
$104M
8
$104M
9
$92.4M
10
$89.8M
11
$59.5M
12
$48.4M
13
$29M
14
$28.7M
15
$25.4M
16
$25.1M
17
$21.5M
18
$20.2M
19
$17.8M
20
$17.6M
21
$15.2M
22
$15.1M
23
$14.7M
24
$14.6M
25
$14.4M